An alternative pathway for reduced folate biosynthesis in bacteria and halophilic archaea.

Mol Microbiol

Department of Molecular Microbiology and Biotechnology, Tel Aviv University, Tel Aviv, 69978, Israel.

Published: December 2004

Whereas tetrahydrofolate is an essential cofactor in all bacteria, the gene that encodes the enzyme dihydrofolate reductase (DHFR) could not be identified in many of the bacteria whose genomes have been entirely sequenced. In this communication we show that the halophilic archaea Halobacterium salinarum and Haloarcula marismortui contain genes coding for proteins with an N-terminal domain homologous to dihydrofolate synthase (FolC) and a C-terminal domain homologous to dihydropteroate synthase (FolP). These genes are able to complement a Haloferax volcanii mutant that lacks DHFR. We also show that the Helicobacter pylori dihydropteroate synthase can complement an Escherichia coli mutant that lacks DHFR. Activity resides in an N-terminal segment that is homologous to the polypeptide linker that connects the dihydrofolate synthase and dihydropteroate synthase domains in the haloarchaeal enzymes. The purified recombinant H. pylori dihydropteroate synthase was found to be a flavoprotein.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2958.2004.04339.xDOI Listing

Publication Analysis

Top Keywords

dihydropteroate synthase
16
halophilic archaea
8
domain homologous
8
dihydrofolate synthase
8
mutant lacks
8
lacks dhfr
8
pylori dihydropteroate
8
synthase
6
alternative pathway
4
pathway reduced
4

Similar Publications

Analysis of Mutations in Dihydropteroate Synthase and Dihydropteroate Reductase Genes Among Non-HIV Patients in China.

Infect Drug Resist

December 2024

Beijing Institute of Tropical Medicine, Beijing Friendship Hospital, Capital Medical University, Beijing, People's Republic of China.

Purpose: pneumonia (PJP) shows a high fatality rate in non-HIV patients. However, there are limited data on drug resistance-related gene mutations in these patients. This study aimed to describe the prevalence of mutations in the dihydrofolate reductase (DHFR) and dihydropteroate synthase (DHPS) genes of in non-HIV patients in China, providing a reference for drug usage.

View Article and Find Full Text PDF

Klebsiella pneumoniae, an opportunistic pathogen, is pervasively distributed across the world. Its escalating antibiotic resistance poses a serious threat to global public health. The mechanisms behind this resistance remain largely elusive.

View Article and Find Full Text PDF

Background: Antimalarial drug resistance is a major challenge in the fight against malaria. Cameroon implemented seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SPAQ) to over 1.5 million children aged 3-59 months from 2016, raising concerns whether drug pressure may lead to a selection of known parasite resistance mutations.

View Article and Find Full Text PDF

Genomic characterization of Achromobacter genogroup 20 and identification of a potential species-specific marker.

J Glob Antimicrob Resist

November 2024

Universidad de Buenos Aires, Facultad de Farmacia y Bioquímica, Instituto de Investigaciones en Bacteriología y Virología Molecular (IBaViM), Laboratorio de Resistencia Bacteriana, Buenos Aires, Argentina; Consejo Nacional de Investigaciones Científicas y Técnicas (CONICET), Buenos Aires, Argentina.

Article Synopsis
  • The study aimed to analyze the genome of Achromobacter genogroup 20 and identify resistance determinants related to antibiotic resistance.
  • Isolate 413638 was classified as Achromobacter genogroup 20 ST365, demonstrating significant resistance to multiple antibiotics and possessing several resistance-related genetic elements, including a newly identified OXA-type β-lactamase.
  • The findings suggest that the resistance markers identified could explain the antibiotic resistance profile of Achromobacter genogroup 20 ST365, with the new OXA variant potentially serving as a useful marker for further species identification.
View Article and Find Full Text PDF

Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012-2022.

Sci Rep

November 2024

Department of Parasite Disease Control and Prevention, Henan Provincial Key Laboratory of Pathogenic Microbiology, Henan Provincial Medical Key Laboratory of Parasitic Diseases and Vector, Henan Province Center for Disease Control and Prevention, Zhengzhou, People's Republic of China.

Article Synopsis
  • Sulfadoxine-pyrimethamine (SP) is crucial for malaria prevention, but parasite resistance poses a challenge, particularly concerning the Pfdhfr and Pfdhps genes associated with SP resistance.
  • A study on 508 P. falciparum isolates from West Africa showed high mutation rates in these genes, with common mutations like Pfdhfr N51I and Pfdhps A437G frequently observed across the region.
  • Despite high resistance, SP may still reduce low birthweight and maternal anemia, highlighting the need for ongoing monitoring of resistance markers to guide effective malaria treatment strategies, especially in pregnant women and infants.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!